3 results match your criteria: "Manipal Heart Institute[Affiliation]"
Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry.
Indian Heart J
May 2014
Head, Department of Cardiology, Manipal Heart Institute, Bangalore 56001, India. Electronic address:
Objective: To study the efficacy and safety of single intravenous bolus administration of indigenously developed tenecteplase (TNK-tPA) in the management of patients with ST-elevation myocardial infarction (STEMI) in clinical practice.
Methods: Observational, prescription-event monitoring study.
Results: Data of 15,222 patients who had STEMI and received weight adjusted TNK injection was analyzed.
Efficacy and safety of tenecteplase in Indian elderly STEMI patients from the Elaxim Indian Registry.
Indian Heart J
August 2012
Department of Cardiology, Manipal Heart Institute, Bangalore, Karnataka, India.
Objective: To analyze the efficacy and safety of indigenous Tenecteplase in Indian elderly STEMI patients in a clinical setting.
Methods: Post-licensure, observational, prescription event monitoring (PEM) study.
Results: 2162 patients received weight-adjusted Tenecteplase injection.
Efficacy & safety of tenecteplase in 6000 patients with ST-elevation myocardial infarction from the Elaxim Indian Registry.
Indian Heart J
January 2013
Manipal Heart Institute, Bangalore, Karnataka, India.
Objective: To study the efficacy and safety of single intravenous bolus administration of indigenously developed tenecteplase in the management of patients presenting with ST-elevation myocardial infarction in clinical practice.
Methods: Post-licensure, observational, prescription-event monitoring study.
Results: Data of 6000 patients who had ST-elevation myocardial infarction and received weight-adjusted tenecteplase injection was analyzed.